credit investor presentation - air liquide · 28 february 2017 credit investor the world leader in...

69
Credit Investor Presentation Solid Performance in 2016 after Airgas Integration Paris, 28 February 2017

Upload: others

Post on 10-Jul-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor Presentation Solid Performance in 2016 after Airgas Integration Paris, 28 February 2017

Page 2: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Agenda

1 A Proven Business Model for Sustainability

2 FY 2016 Activity

• Solid Operational Performance

• Improved Investment Portfolio Profile

• 2017: Delivering NEOS

3 Group Credit Profile

4 Appendix

2

Page 3: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

A Proven Business Model for Sustainability

3

Page 4: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

The World Leader in Gases, Technologies and Services

4

Established in 1902

67,000 Employees

80+ Countries

€18.1bn Sales

16.7% OIR margin

€1.8bn Net Profit 3M+

Customers & patients

2016 figures

Page 5: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Ideally Positioned for Growth over the Long-term

AMERICAS

64%

6% 9%

21%

EUROPE

32%

27%

5%

36%

ASIA

23%

AMERICAS

36%

MIDDLE EAST & AFRICA

3%

EUROPE

38%

€17,331m

GAS & SERVICES FY 2 0 1 6

REVENUE

Large Industries Electronics Healthcare Industrial Merchant

€6.2bn

€6.6bn

31%

3%

35%

31%

€3.9bn

ASIA-PACIFIC

5

Page 6: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Major Steps Successfully Achieved in 2016

Divestiture of Other

Activities

Rights Issue

● US divestitures

● Rights issue

● € and US$ bonds issue

● Merger of operations

● Customer-centric transformation

● 2020 ambition

● New organization

● Focus on Gas & Services and GMT

6

Page 7: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

2016 Highlights

14

15

16

17

18

19

2013 2014 2015 2016

€bn

€18.1bn

Group Sales

+2.7%*

Gearing

Gearing back <100% 90%

Cash Flow

Strong performance 20.4% of sales

NB: 2015 figures have been restated to account for IFRS 5, discontinued operations

Net Profit

In line with guidance +5.0%

+14.6%

7

Page 8: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

A Changing Environment

8

Health and wellness

Globalwarming

Sustainability

Sharing economy

Wastemanagement

Rise of chronic diseases

Urbanization

Evolution of Healthcare systems

Ageingpopulation

New distribution models

Value migration:rise of services

Customer experience and satisfaction

Digitalization

Rise of platformsin industries

Moderate and balanced world growth

Rebalance of geopolitical powers

Evolving energy economics

Low inflation and low cost of money

Economic transition in China

Transparency across the value chain

War for talents

New purchasing behaviors

Energy and Environment

Transition

Changes in Healthcare

Digitization

Page 9: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Air Liquide Ambition

9

• Lead our industry

• Deliver long-term performance

• Contribute to sustainability

Page 10: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Strategy: a Customer-centric Transformation

10

Operational Excellence

Selective Investments

Open Innovation

Network Organization

Profitable Growth over the Long-term

o Aligned with Air Liquide new business profile

o Customer experience o Cost competitiveness

o Core o Disruptive

o Digital workplace o Speed o Best practices

For

Page 11: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Financial Objectives

11

(1) Including Airgas scope effect in 2017 contributing +2% to the CAGR (2) Over the 2017-2020 period

+6% to +8%

CAGR 2016-2020(1)

>10% after 5-6 years

Efficiencies >€300m on average/year(2)

+ Airgas synergies >$300m

Maintain “A” range rating

Capex/Sales 2017-2020: 10% to 12%

Page 12: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Corporate Sustainability Objectives

12

• Help customers lower GHG*

emissions

• Grow with reduced carbon intensity

• Continue to improve Safety

• Do business responsibly

• Extend Air Liquide Foundation

• Foster clean mobility

• Develop Healthcare

*GreenHouse Gas

e.g.

e.g.

FOR BETTER HEALTH

FOR BETTER ENVIRONMENT

e.g.

Page 13: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

A Strong Business Model

13

Electricity

Natural gas

Water

ESG(d)

Healthcare

Large Industries

Industrial Merchant

Electronics

Air Liquide Activities

Home healthcare

Patient

Filling

center

SMR(a)

ASU(b)

Filling center

On-site (c)

customer

Hospital

Bulk and Cylinder

Customer

Metal

Producer

Refinery

Chemical

Producer ESG(d)

Filling center

Electronics

Customer

ASU(b)

Mutualize assets

Liquefaction piggyback

Distributors, bolt-on acquisitions

1

2

3

(a) SMR: Hydrogen and carbon monoxide production unit (Steam Methane Reformer) (b) ASU: Air gases production unit (Air Separation Unit)

(c) On-site: Small local production unit (d) ESG: Electronic Specialty Gases

Page 14: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Relying on a New Balanced Mix

14

2016

2015

ASIA

23%

AMERICAS

36%

MIDDLE EAST & AFRICA

3%

EUROPE

38%

ASIA

26%

AMERICAS

24%

MIDDLE EAST & AFRICA

4%

EUROPE

46%

ELECTRONICS

9%

HEALHTCARE

18%

INDUSTRIAL MARCHENT

44%

LARGE INDUSTRY

29%

ELECTRONICS

10%

HEALHTCARE

19%

INDUSTRIAL MARCHENT

36%

LARGE INDUSTRY

35%

Page 15: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Large Industries Strategy

15

• Turn technology into long-term cash flow

• Expand opportunities geographies and markets

• Strengthen integration industrial basins, other Business Lines, technologies

• Execute flawlessly

• Focus on key projects

• Continued outsourcing trend

• Build on leadership in dynamic industrial basins

AIR LIQUIDE FUNDAMENTALS

Page 16: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Industrial Merchant Strategy

16

• Customer loyalty

• Multiple products serving multiple end markets

• Optimized supply chain to ensure customer proximity

• Extend customer reach through Airgas & multi-channels

• Enrich product, application and service mix through innovation

• Reinforce competitiveness through asset optimization & digital

AIR LIQUIDE FUNDAMENTALS

Page 17: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Industrial Merchant Strategy

17

Liquid bulk

Fill plant

Direct delivery Retail Telesales e-commerce

Large Industries Merchant bulk Packaged gas

Liquid bulk

Pipeline &on-sites

Bulkdeliveries

Fill plant Fill plant

Primaryproduction

• Market coverage

• Cost synergies

• Improved customer service

• Supply chain optimization

• Leading position in new digital channels

Unique US Business Combination

Page 18: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Medical

Gases

• Medicalization

• Geographical expansion

• Patient-centric services

• Organic & external growth

• Strong back office

Healthcare Strategy

18

• Further expand the model

• Accelerate innovation

AIR LIQUIDE FUNDAMENTALS

Home

Health

Care

Page 19: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Electronics Strategy

19

• Portfolio focused on added value products

• Strong positions with major customers

• Proprietary molecules developed with customers

• Leverage on leadership position in key countries including China

• Reduce exposure to cycles

AIR LIQUIDE FUNDAMENTALS

Page 20: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Global Markets & Technologies Strategy

20

• Develop innovative technologies

• Open new markets on a global scale

• Further develop extreme cryogenics and aerospace

• Accompany energy transition with new value chains: H2 energy, biomethane, clean transportation

AIR LIQUIDE FUNDAMENTALS

Page 21: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

0,0

0,5

1,0

1,5

2,0

2,5

1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014 2016

0

1

2

3

4

5

6

1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014 2016

Regular and Sustained Performance

0

3 000

6 000

9 000

12 000

15 000

18 000

1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014 2016

0

500

1 000

1 500

2 000

2 500

3 000

3 500

1986 1988 1990 1992 1994 1996 1998 2000 2002 2004 2006 2008 2010 2012 2014 2016

Revenue (in €m) EPS(1) (in €)

Cashflow (in €m)

(1) Adjusted for the 2-for-1 share split in 2007, for attribution of free shares and for a factor of 0.974 reflecting the value of the rights of the capital increase completed in October 2016. (2) Calculated according to prevailing accounting rules over 30 years.

Dividend(1) (in € per share)

21

CAGR over 30 years(2)

+6.0%

CAGR over 30 years(2)

+7.2%

CAGR over 30 years(2)

+6.9%

CAGR over 30 years(2)

+8.2%

Page 22: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

FY 2016 Activity

Solid Operational Performance

22

Page 23: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Sales in €m

FY 15

FY 16

FY 16/15 as published

FY 16/15 comparable (2)

Q4 16/15 comparable (2)

Gas & Services 14,752 17,331 +17.5% +2.7% +1.7%

Engineering & Construction 775 474 -38.8% -38.0% -34.5%

Global Markets & Technologies 292 330 +13.2% +13.6% +20.0%

Group Total 15,819 18,135 +14.6% +0.9% +0.5%

Sales Growth Above Market

(1) Industrial Production weighted average by Air Liquide industrial sales footprint. (2) Estimated comparable growth: excluding Currency, Energy and Airgas impact. NB: 2015 figures have been restated to account for IFRS 5, discontinued operations.

INDUSTRIAL PRODUCTION

FY 2016

+0.5% (1)

23

Page 24: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Stabilizing Economic Backdrop

Source Coe-Rexecode as of January 2017

Energy Impact*

-2.2%

FX Impact*

-1.4%

Industrial Production

Year on Year in % (3-month rolling average)

World

United States

Euro Zone

Developing Economies

2013 2014 2015 2016

-4%

-2%

0%

2%

4%

6%

8%

+0.1%

+0.4%

Q4 2016 FY 2016

Q4 2016 FY 2016

*On Group sales

24

Page 25: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Strong Growth Drivers in 2016

+5%

+8% +5%

LARGE INDUSTRIES

AIRGAS INTEGRATION

HEALTHCARE DEVELOPING ECONOMIES

+14%

GLOBAL MARKETS & TECHNOLOGIES

Sales Growth excluding Currency, Energy and Airgas impact.

Comparable sales growth for Americas for Q4 16 and FY16 are estimated due to the merger of Airgas and Air Liquide US operations.

25

Page 26: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

+0.3% +1%

+3% +3%

-0,2% FY2015 Q1 Q2 Q3 Q4

Q4 - Better Europe, Stable Americas

• LI: good volumes in air gases, positive one-off

• IM: confirmed bulk volumes increase, positive Food, low Fabrication; growth in South West Europe

• HC: steady organic growth

(1) Comparable growth: excluding Currency, Energy and Airgas impact. Comments relate to Q4 2016.

Comparable sales growth for Americas for Q4 16 and FY16 is estimated due to the merger of Airgas and Air Liquide US operations

€6,593m

EUROPE FY 2016

• LI: record volumes of air gases in US, several H2 turnarounds

• IM: better bulk volumes in US

• EL: lower E&I sales

• HC: pursued development in South America

€6,230m

AMERICAS FY 2016

+2% FY +2% FY

-0.2%

Q4

+120%

Q4 incl. Airgas

G&S Comparable Sales Growth(1)

+3% +2% +2%

+0.5%

+4%

FY2015 Q1 Q2 Q3 Q4

Improved Q4 IM still weak but positive signals

26

Page 27: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Q4 - Solid Fundamentals in Asia, Turnaround in MEA

+6% +7%

+6%

+4%

+0.5%

FY2015 Q1 Q2 Q3 Q4

+4% FY

+3% +2%

-8%

+8% FY

€3,936m

ASIA-PACIFIC FY 2016

€572m

MIDDLE-EAST & AFRICA

FY 2016

• Modest growth in South Africa

• Low IM except dynamic Egypt

• Turnarounds in LI

• Flat EL: high 2015 basis in E&I and neon; China, Taiwan, Singapore >+9%

• Strong IM in China

• Australia back to slight growth

+24% +45%

Q4

Q3 Q2 Q1 FY2015

G&S Comparable Sales Growth(1)

(1) Comparable growth: excluding Currency, Energy and Airgas impact. Comments relate to Q4 2016.

Positive underlying activity Yanbu turnaround in KSA

27

Page 28: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Q4 - Solid LI, Slightly Better IM

• Strong air gases volumes

• Positive one-off in Europe

• Several significant turnarounds

LARGE INDUSTRIES

FY 2016

€5,037m

INDUSTRIAL MERCHANT

FY 2016

€7,565m

29%

FY 2016

+5%

+9%

+4% +5%

+4%

FY2015 Q1 Q2 Q3 Q4

+5% FY

-1%

-3%

-1% -2%

-1%

FY2015 Q1 Q2 Q3 Q4

-2% FY

44%

FY 2016

G&S Comparable Sales Growth(1)

(1) Comparable growth: excluding Currency, Energy and Airgas impact. Comments relate to Q4 2016.

Comparable sales growth for Americas for Q4 16 and FY16 is estimated due to the merger of Airgas and Air Liquide US operations

• Food up, Manufacturing stabilizing, Construction down

• Bulk volumes up in Europe and Asia

• Better pricing

+74%

Q4 incl. Airgas

Turnarounds compensated by one-off Positive signals in contrasted markets

28

Page 29: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Q4 - Sound HC, Steady Underlying in EL

HEALTHCARE FY 2016

€3,111m

ELECTRONICS FY 2016

€1,618m

+8%

+4% +5% +5% +5%

FY2015 Q1 Q2 Q3 Q4

+11% +13%

+9%

-1%

-3%

18%

FY 2016 9% FY 2016

Q4 Q3

Q2 Q1 FY2015

(1) Comparable growth: excluding Currency, Energy and Airgas impact. Comments relate to Q4 2016.

Comparable sales growth for Americas for Q4 16 and FY16 is estimated due to the merger of Airgas and Air Liquide US operations

(2) Electronics Specialty Materials

G&S Comparable Sales Growth(1)

• Increased number of patients in Home Healthcare

• Low contribution from bolt-on M&A

• Strong Hygiene and Specialty Ingredients

• Lower E&I

• ESM(2) impacted by neon sales

• Solid Carrier Gases growth

• Dynamic Advanced Materials

+5% FY +4% FY

+17%

Q4 incl. Airgas

Solid organic growth Growth of recurring sales

29

Page 30: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

E&C Low, GMT Developing

266 255

172

243

73 53

119 144

0

100

200

300

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

Order Intake(1)

Sales

E&C GMT

44 35

113

88 85 104

55

161

0

100

200

300

Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4

2015 2016 2015 2016

In €m

€292m

936 389 280 405 In €m

€330m €474m €775m

(1) Group and Third Party Orders.

30

Page 31: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

In €m

2015

2016

FY 16/15

Revenue

Purchases

Personnel expenses

Other net income and expenses

15,819

(5,890)

(2,929)

(2,785)

18,135

(6,693)

(3,659)

(3,172)

+14.6%

+13.6%

Operating profit before depreciation

Depreciation and amortization

Operating Income Recurring (OIR)

4,215

(1,359)

2,856

4,611

(1,587)

3,024

+9.4%

+16.8%

+5.9%

OIR margin 18.1% 16.7% -140bps

OIR margin excluding energy effect

16.4%

-170bps

OIR Margin Reflecting New Mix with Airgas Consolidation

+19.6%

NB: 2015 figures have been restated to account for IFRS 5, discontinued operations.

31

Airgas consolidation Low margin

in E&C

Page 32: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

0

50

100

150

200

250

300

350

2008 2009 2010 2011 2012 2013 2014 2015 2016 2017

Level of Efficiencies Aligned with NEOS

In €m

Objective Efficiencies

Breakdown of Efficiencies

Industrial Merchant

Large Industries

Healthcare

Electronics

Procurement

Industrial

Others

E&C, GMT, Corporate

NB: 2015 figures have been restated to account for IFRS 5, discontinued operations.

€315m

32

Page 33: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

First Airgas Synergies Delivered in 2016

$45m

• Business & administrative process review

• Procurement

• 18 site closures

• Logistics optimization

• Elimination of redundancies

• Sourcing

• Primary production

• Logistics optimization

• Leverage on IT

• Shared services

• Delisting

• Management

CYLINDER

OPERATIONS BACK

OFFICE

PROCESS

&

PROCUREMENT

BULK

OPERATIONS

Cost Synergies on track

33

Page 34: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

2017-2019: Synergies > US$300m Confirmed

Revenue Synergies Cost Synergies

CYLINDER

OPERATIONS

PROCESS

&

PROCUREMENT

BULK

OPERATIONS

Timeline for delivery of synergies

US$45m >US$130m >US$65m >US$60m

• Cross-selling

• Product availability

• Gas applications

• Small on-site generators

BACK

OFFICE

Costs Synergies

Revenue Synergies

2016 2017 2018 2019

34

Page 35: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Net Profit Up +5.0%

In €m 2015 2016 FY 16/15

Revenue

Operating Income Recurring

Other non-recurring operating income & expenses

15,819

2,856

(123)

18,135

3,024

36

+14.6%

+5.9%

Operating Income 2,733 3,060 +12.0%

Net financial costs and other net financial expenses

Income taxes

Tax rate

(262)

(661)

26.8%

(403)

(747)

28.2%

Share of profit of associates

Minority interests

13

(82)

6

(83)

Profit from discontinued operations 15 11

Net profit (Group share) 1,756 1,844 +5.0%

Earnings per share (in €) 4.99 5.11 +2.4%

2016 one-off

costs fully covered

NB: 2015 figures have been restated to account for IFRS 5, discontinued operations.

35

Page 36: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

FY 2016 Activity

Improved Investment Portfolio Profile

36

Page 37: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Improved Investment Portfolio Profile

FY 2016 Investment Decisions(1)

• Smaller projects

• Lower risk

• Increased selectivity on projects

• Airgas ~€230m, including 9 acquisitions

Investment Opportunities(1)

12 months portfolio

FY 2016 Start-up/ Ramp-up Sales Growth

Contribution

• ASUs in Americas and Australia

• 3 IM and 4 EL units in Asia

(1) See definitions in appendix.

€2.2bn ~€225m

2015 2016

€2.4bn €2.2bn

37

Page 38: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Dec 2013 Dec 2014 Dec 2015 Decisions Start-ups Dec 2016

Investment Backlog Adjusting for Start-ups

~€ 0.8bn

Start-ups

€2.7bn

Decisions €2.8bn

€2.3bn

€2.1bn

Investment Backlog(1) FY 2016

(1) See definitions in appendix.

Yearly Sales Backlog(1)

after full Ramp-ups

38

Page 39: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

In €m

Focus on ROCE

• Short-term impact of Airgas acquisition

• Expected lower capex on sales

• Focus on delivering efficiencies and synergies

* Published ROCE vs. “pro forma” ROCE of 6.9%

0%

5%

10%

2016 2017…

WACC

Value creation

ROCE

7.8%*

350 bps

39

ROCE

>10%

after 5-6 years

Page 40: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

FY 2016 Activity 2017: Delivering NEOS

40

Page 41: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

2016 PERFORMANCE

2016: Transition to NEOS

GROWTH & CASH EXPANSION PREMIUM

VALUE NEW

BUSINESSES

CUSTOMER REACH &

COMPETITIVENESS

• +5.4% sales growth

• New long-term contracts with tier-1 customers

• >US$45m of synergies

• Airgas operations merged

• Leveraging on multi-channel customer reach

• >+13% sales growth including Airgas

• Expanding geographies and portfolio of therapies

• >+19% Advanced Materials

• Sales mix favorable to margins

• >+13% sales growth

• Major contracts in Space

LI IM HC EL GMT

41

Comparable sales growth: excluding Currency, Energy and Airgas impact; except for HC including Airgas impact.

Page 42: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

2017 Outlook

● Acquisition fully completed

● Solid operational performance

● Improved investment portfolio profile

● Transition to NEOS

“Assuming a comparable environment, Air Liquide is confident in its ability to deliver net profit growth in 2017”

42

● Steady underlying activity

● Positive signals from customers

● Delivering expected efficiencies and synergies

● Focus on value creation

2016 2017

Page 43: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Group Credit Profile

43

Page 44: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Gearing at 90%

44

<15,368>

+3,523

+3,365

Net Debt 31 Dec 2016

Cash Flow

<2,028>

WCR + Others

Net Debt 31 Dec 2015

<7,239>

Currency & Scope

<1,019>

Dividends Airgas acquisition

net of divestitures

Rights Issue

Net investments excl. Airgas

acquisition(1)

+173

<11,580>

<563>

GEARING

57%

(1) Including acquisitions, transactions with minority shareholders, net of divestitures, excluding Airgas acquisition.

GEARING

90%

CASH FLOW

+30.5%

Page 45: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

1,65 1,49 1,47 1,61 1,59 1,63 1,70

3,3

2 000

4 000

6 000

8 000

10 000

12 000

14 000

16 000

2009 2010 2011 2012 2013 2014 2015 2016

Net Debt Net Debt / EBITDA

Net Debt ratios under control

45

DEBT / EQUITY

63%

DEBT / EQUITY

55%

DEBT / EQUITY

53%

DEBT / EQUITY

58%

DEBT / EQUITY

56%

DEBT / EQUITY

53%

DEBT / EQUITY

57%

DEBT / EQUITY

90%

In €m

3,3x

Page 46: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Reduced Cost of Debt

46

Net debt by currency

EUR

25%

USD

59%

JPY

4%

RMB

5%

OTHERS

7%

Average cost of net debt

2,00%

3,00%

4,00%

5,00%

2008 2009 2010 2011 2012 2013 2014 2015 2016

-80bps 3.7%

2.9%

Page 47: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Financing Structure As of 31 December 2016

BANK DEBT

9%

PRIVATE PLACEMENTS

OTHERS(1)

COMMERCIAL PAPER

(1) Others: Finance leases and put options granted to minority shareholders.

Sources Fixed/variable rates

(gross debt)

FIXED RATE

84%

VARIABLE RATE

16%

BONDS

MARKET DEBT

90%

75%

11%

4% 1%

47

Page 48: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

€4.6bn

Prudent Liquidity Management As of 31 December 2016

48

0

4000

8000

12000

16000

> 2021

2018 à 2021

2017

Group gross debt maturity profile Available liquidity

CASH AND CASH EQUIVALENT

33%

CONFIRMED CREDIT LINES

67%

In €m

• Holdings’ Confirmed Credit Lines are a mix of bilateral facilities and a €1.3bn Revolving Credit Facility.

• In 2016, the committed amount of bilateral facilities has been increased from €1.3bn to €1.8bn and maturities extended.

Page 49: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health 49

750

170

565500 500 489 500 500

150 100 122

457

300

379

190

95

116

308

640

237

285

500

500500

500

1 000

712949

712

1 186

712

0

200

400

600

800

1 000

1 200

1 400

1 600

1 800

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 >2029

EMTN - ALFIN EMTN - ALSA USPP CNY Bond Airgas Senior Notes EMTN EUR for Airgas refinancing 144A/Reg S for Airgas refinancing

In €m

Diversified market debt well spread over time As of 31 December 2016

Page 50: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

“A” Long Term Credit Rating Commitment

50

■ Long-term rating: A-

■ Short-term rating: A-2

■ Outlook: Stable on May 24, 2016

■ Rationale:

○ “Excellent Business Risk as well as adequate Liquidity and a significant Financial Risk. S&P puts a strong focus on Air Liquide‘s earnings resilience and stable cash flow generation when analyzing the company's profitability and financial metrics.”

○ “The rating also reflects the company's stable and predictable cash flow and revenue, despite its extensive debt. The stable outlook reflects S&P‘s forecast that France-based industrial gas company Air Liquide will perform the announced capital increase of between 3 to 3.5 billion euros, while controlling its investments to progressively enhance its financial leverage.”

■ Long-term rating: A3 (first long-term rating)

■ Short-term rating: P-2

■ Outlook: Stable on May 24, 2016

■ Rationale:

○ “Stable and predictable cash flow generation supported by high barriers to entry, the low exposure to cyclical end-markets, ongoing efficiency gains and the ability to pass on most of increased input costs to Large Industries and Bulk customers through price escalation clauses.”

○ “Combined credit metrics have weakened as a result of the closing of the Airgas acquisition, but is expected to improve gradually to get back to levels more commensurate with the A3 rating by 2018. The rating also acknowledge the strong strategic rationale of the acquisition as it will increase Air Liquide's density in the US market, a key success factor in this industry.”

Page 51: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Appendix

51

Page 52: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

2017: Delivering NEOS

● Airgas synergies

● Efficiencies

● Customer reliability

● Focus on ROCE

● “LI Connect”

● i-Lab initiatives

● Connected cylinder

● e-Health

● Open innovation

● ALIAD

● Hydrogen Council

● Biogas

52

Page 53: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health 53

Impact of Currency and Energy on G&S Revenue

In €m Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Q2 16 Q3 16 Q4 16

€/US$ €/CNY €/JP¥ Others

+109 +52 +11 +78

+129 +76

+9 +76

+110 +52

+3 +4

+91 +36 +17 (22)

+14 (10) +14 (89)

(14) (28) +22 (98)

(3) (23) +42 (32)

+10 (20) +30 (17)

Total currency impact +250 +290 +169 +122 (71) (119) (16) +3

Average rate Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Q2 16 Q3 16 Q4 16

€/US$ €/CNY €/JP¥

1.13 7.04

134.6

1.10 6.85

134.0

1.11 7.01

135.9

1.10 7.00

132.9

1.10 7.21

127.0

1.13 7.38

121.9

1.12 7.44

114.3

1.08 7.37

117.8

Natural Gas Impact (116) (77) (55) (114) (108) (94) (82) +13

In €m

Electricity Impact (8) (17) (16) (4) (36) (32) (18) +3

Currency

Natural Gas

Electricity In €m

Page 54: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health 54

Consolidated P&L

In €m 2015 2016

Revenue

Cost of Goods

Operating income recurring before depreciation

Depreciation and amortization expense

15,819

(11,604)

4,215

(1,359)

18,135

(13,524)

4,611

(1,587)

Operating income Recurring

Net non-recurring operating income

Operating income

Net finance costs & other net financial expenses

Income taxes

Share of profit of associates

Net income from discontinued operations

2,856

(123)

2,733

(262)

(661)

13

15

3,024

36

3,060

(403)

(747)

6

11

Profit for the period -Minority interest

- Net profit (Group share)

1,838

82

1,756

1,927

83

1844

Basic earnings per share (in €) (1) 4.99 5.11

(1) 2015 Net earnings per share restated for the impact of the preferential subscription rights allocated to Group shareholders as part of the capital increase NB: 2015 figures have been restated to account for IFRS 5, discontinued operations.

Page 55: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health 55

Consolidated Balance Sheet - In €m

ASSETS 31/12/15 31/12/16

Goodwill

Fixed assets

Other non-current assets*

5,730

16,555

936

13,890

22,003

960

Total non-current assets 23,221 36,853

Inventories & work in-progress

Trade receivables & other current assets

Cash and cash equivalents*

981

3,711

1,028

1,323

4,090

1,576

Total current assets 5,720 6,989

Assets held for sale - 276

Total assets 28,941 44,118

EQUITY AND LIABILITIES 31/12/15 31/12/16

Shareholders’ equity Minority interests

12,406 365

16,742 383

Total equity 12,771 17,125

Provisions & deferred tax liabilities Non-current borrowings Other non-current liabilities*

3,435 6,291

475

4,971 14,890

504

Total equity and non current liabilities

22,972 37,490

Provisions Trade payables & other current liabilities Current borrowings*

271 3,728 1,970

280 4,103 2,064

Total current liabilities 5,969 6,447

Liabilities held for sale - 181

Total equity and liabilities 28,941 44,118

31/12/15 31/12/16

Net debt 7,239 15,368

Net debt ratio 56.7% 89.7%

* Including fair value of derivatives.

Page 56: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health 56

Cash Flow Statement

In €m 2015 2016

Funds provided by operations 3,150 3,523

Changes in Working Capital

Other items

(258)

(60)

331

(158)

Net cash from operating activities 2,832 3,696

Purchase of PPE* and intangible assets

Purchase of financial assets and the impact of changes in scope

Proceeds from sale of PPE*, intangible and financial assets

(2,028)

(384)

131

(2,259)

(12,165)

830

Net cash in investing activities (2,281) (13,594)

Distribution (975) (1,019)

Increase in capital stock

Purchase of treasury shares

Transactions with minority shareholders

Impact of Exchange rate changes and net indebtedness of newly consolidated companies & others

86

(178)

(11)

(406)

3,361

4

14

(563)

Change in net indebtedness (933) (8,129)

* Property, plant and equipment.

Page 57: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Growth in Q4 G&S Revenue

2 000

2 500

3 000

3 500

4 000

4 500

5 000

in €m

4,930

0

+15 +63 3,768

Comparable (1) growth Energy Currency

+3

Significant perimeter Q4 2016

+1,081

Comparable growth(1)

+30.8% +1.7%

Q4 2015

Published growth

+0.0% +0.4%

(1)

+28.7%

57

(1) Comparable growth: excluding Currency, Energy and Airgas impact.

Comparable sales growth for Americas for Q4 16 and FY16 is estimated due to the merger of Airgas and Air Liquide US operations

Page 58: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Sales in €m

Q4 15

Q1 16

Q2 16

Q3 16

Q4 16

Q4 16/15

Q4 16/15 comparable(1)

Europe 1,713 1,614 1,611 1,601 1,767 +3.2% +4.2%

Americas 899 824 1,361 2,042 2,003 +122.9% -0.2%

Asia-Pacific 995 966 954 997 1,019 +2.4% +0.5%

Middle-East and Africa 161 144 144 143 141 -12.1% -7.6%

Gas & Services 3,768 3,548 4,070 4,783 4,930 +30.8% +1.7%

Engineering & Construction 173 124 130 105 115 -34.0% -34.5%

Global Markets & Technologies 93 65 81 73 111 +19.5% +20.0%

GROUP TOTAL 4,034 3,737 4,281 4,961 5,156 +27.8% +0.5%

Revenue Analysis by Quarter and by Geography

58

(1) Comparable growth: excluding Currency, Energy and Airgas impact.

Comparable sales growth for Americas for Q4 16 and FY16 is estimated due to the merger of Airgas and Air Liquide US operations.

NB: 2015 figures have been restated to account for IFRS 5, discontinued operations.

Page 59: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Sales in €m

Q4 15

Q1 16

Q2 16

Q3 16

Q4 16

Q4 16/15

Q4 16/15 comparable(1)

Large Industries 1,324 1,207 1,181 1,261 1,388 +4.8% +4.2%

Industrial Merchant 1,314 1,238 1,726 2,308 2,293 +74.5% -1.1%

Healthcare 725 695 756 814 846 +16.7% +4.8%

Electronics 405 408 407 400 403 -0.5% -3.5%

Gas & Services 3,768 3,548 4,070 4,783 4,930 +30.8% +1.7%

Engineering & Construction 173 124 130 105 115 -34.0% -34.5%

Global Markets & Technologies 93 65 81 73 111 +19.5% +20.0%

GROUP TOTAL 4,034 3,737 4,281 4,961 5,156 +27.8% +0.5%

59

Revenue Analysis by Quarter and by Business Line

(1) Comparable growth: excluding Currency, Energy and Airgas impact.

Comparable sales growth for Americas for Q4 16 and FY16 is estimated due to the merger of Airgas and Air Liquide US operations.

NB: 2015 figures have been restated to account for IFRS 5, discontinued operations.

Page 60: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Growth as published

Natural Gas Electricity Currency Significant perimeter

Comparable growth (1)

Q1 2015 + 6.2% - 3.4% - 0.2% + 7.3% 0.0% + 2.6%

Q2 2015 + 9.3% - 2.2% - 0.5% + 8.5% 0.0% + 3.5%

Q3 2015 +7.4% -1.6% -0.4% + 4.9% 0.0% + 4.5%

Q4 2015 +4.9% -3.2% -0.1% + 3.4% 0.0% + 4.8%

Q1 2016 -1.8% -3.0% -1.0% -2.0% 0.0% +4.2%

Q2 2016 +10.3% -2.6% -0.9% -3.2% +13.9% +3.1%

Q3 2016 +29.9% -2.3% -0.5% -0.4% +31.1% +2.0%

Q4 2016 +30.8% +0.4% +0.0% +0.0% +28.7% +1.7%

60

G&S Revenue Growth by Quarter and by Impact

(1) Comparable growth: excluding Currency, Energy and Airgas impact.

Comparable sales growth for Americas for Q4 16 and FY16 is estimated due to the merger of Airgas and Air Liquide US operations

Page 61: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Europe Q4 Gas & Services Sales: €1,767m

Q4 16/15 Comparable change (1): +4.2% In €m

FY 2016

Published growth

Comparable growth(1)

Sales 6,593 -2.3% +2.0%

OIR 1,319 -0.5%

OIR/Sales 20.0% +40bps -30bps(2)

(1) Excluding significant scope, currency and energy impact.

(2) Excluding energy impact.

61

INDUSTRIAL MERCHANT

• Confirmed bulk volume increase

• Encouraging signs in cylinder business

• Food & Pharma up, Manufacturing low

• Dynamic Eastern Europe

• Good volumes in air gases

• Positive one-off • Robust growth in Eastern Europe

• Steady organic growth

• Low contribution from bolt-on M&A

• Strong Hygiene

LARGE INDUSTRIES HEALTHCARE

-0.5%

+8.0%

+4.7%

29% 3%

34% 34%

Page 62: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Americas Q4 Gas & Services Sales: €2,003 m

62

INDUSTRIAL MERCHANT

• Still weak in North America

• Better bulk volumes in US

• Volumes low in Energy, Metal Fab and Construction, solid in Food & Pharma

• Record volumes of air gases in US

• Several H2 turnarounds

• Continued double-digit growth in South America

• Dynamic South America

• Solid organic growth and contribution from an acquisition in Canada

LARGE INDUSTRIES HEALTHCARE

• Low E&I sales

ELECTRONICS

Q4 16/15 Comparable change(1): -0.2% In €m

FY 2016

Published growth

Comparable growth(1)

Sales 6,230 +73.3% +1.8%

OIR 1,076 +27.7%

OIR/Sales 17.3% -620bps -630bps(2)

-2.8%

+6.1%

+5.2%

68%

5%

9%

18%

-14.9% +120%

Q4 incl. Airgas

(1) Comparable growth: excluding Currency, Energy and Airgas impact.

Comparable sales growth for Americas for Q4 16 and FY16 is estimated due to the merger of Airgas and Air Liquide US operations.

(2) Excluding energy impact.

Page 63: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Asia-Pacific Q4 Gas & Services Sales: €1,019m

63

INDUSTRIAL MERCHANT

• Back to slight growth

• Bulk & cylinder volume growth >+9% in China

• Flat Japan

• Positive pricing

• Several maintenance turnarounds

• Ramp-up of a new unit in Australia

LARGE INDUSTRIES

• Flat growth

• Low E&I & ESM in NE Asia

• High neon price in Q4 2015 impacting ESM

• Carrier gases sales growth >+5%

ELECTRONICS

Q4 16/15 Comparable change(1): +0.5% In €m

FY 2016

Published growth

Comparable growth(1)

Sales 3.936 +2.2% +4.2%

OIR 730 +4.0%

OIR/Sales 18.5% -30bps 0bp(2)

+0.1%

+0.6%

+5.7%

33%

26%

5%

36%

+0.0%

(1) Excluding significant scope, currency and energy impact.

(2) Excluding energy impact.

Page 64: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

+0.5%

+1.6%

-0.3%

+2.5%

-0.7%

+0.9%

+3.7%

+0.9%

+2.6%

-0.7%

64

Industrial Merchant Pricing

Europe

Americas

Asia-Pacific

Middle-East and Africa

Q4 2016

FY 2016 TOTAL

INDUSTRIAL MERCHANT

Page 65: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health 65

Operating Margin – Energy Effect

Group, in €m 2015 2016

Revenue

Incl. energy effect

Operating income recurring

Operating margin

Operating margin excluding energy

15,819

-406

2,856

18.1%

18,135

-356

3,024

16.7%

16.4%

Gaz & Services, in €m 2015 2016

Revenue

Incl. energy effect

Operating income recurring

Operating margin

Operating margin excluding energy

14,752

-406

2,960

20.1%

17,331

-356

3,239

18.7%

18.3%

NB: 2015 figures have been restated to account for IFRS 5, discontinued operations.

OIR Margin Reflecting New Mix with Airgas Consolidation

Page 66: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health 66

Operating Margin (OIR/Revenue)

H1 15 H2 15 2015

2015 Group

Gas & Services

17.7%

19.4%

18.4%

20.7%

18.1%

20.1%

H1 16 H2 16 2016

2016 Group

Gas & Services

17.0%

19.1%

16.4%

18.3%

16.7%

18.7%

H2 16 H1 16 2016

H2 15 H1 15 2015

NB: 2015 figures have been restated to account for IFRS 5, discontinued operations.

OIR Margin Reflecting New Mix with Airgas Consolidation

Page 67: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Investment Cycle – Definitions

67

● Investment opportunities at end of the period

– Investment opportunities under consideration by the Group for decision within 12 months.

– Industrial projects with investment value > €5m for Large Industries and > €3m for other business lines.

– Includes asset replacements or efficiency projects. Excludes maintenance and safety.

● Investment backlog at end of the period

– Cumulated industrial investment value of projects decided but not yet started.

– Industrial projects with value > €10m, including asset replacements or efficiency projects, excluding maintenance and safety.

●Sales backlog

– Cumulated expected sales per year generated by the current investment backlog after full ramp-up.

●Decisions of the period

– Cumulated value of industrial and financial investment decisions.

– Industrial, growth and non-growth projects including asset replacements, efficiency, maintenance and safety.

– Financial decisions (acquisitions).

Page 68: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health

Gas & Services Industrial Capex by Geography

G&S 2016 capex(1) €2.1bn G&S capex(1) / sales

2015 2016

Europe

Americas

Asia-Pacific

Middle-East and Africa

8.1%

20.3%

12.3%

23.1%

8.6%

11.8%

15.2%

27.1%

Total 12.8% 11.9%

ASIA

29%

AMERICAS

36%

MIDDLE EAST & AFRICA

8%

EUROPE

28%

(1) Gross industrial investments.

68

Page 69: Credit Investor Presentation - Air Liquide · 28 February 2017 Credit investor The world leader in gases, technologies and services for Industry and Health Agenda 1 A Proven Business

Credit Investor 28 February 2017 The world leader in gases, technologies and services for Industry and Health 69

L’Air Liquide S.A.

Corporation for the study and application of processes developed by Georges Claude au

capital de 2 138 941 915,00 euros

Corporate Headquarters:

75, Quai d’Orsay

75321 Paris Cedex 07

Tel : +33 (0)1 40 62 55 55

RCS Paris 552 096 281

Follow us on Twitter @AirLiquideGroup www.airliquide.com

For further information, please contact:

Investor Relations

Aude Rodriguez + 33 (0)1 40 62 57 08

Louis Laffont + 33 (0)1 40 62 57 18

Erin Sarret + 33 (0)1 40 62 57 37

Jérôme Zaman + 33 (0)1 40 62 59 38

Joseph Marczely + 1 610 263 8277

Group Financing and Rating

Jacques Molgo + 33 (0)1 40 62 57 75

Aude Revel + 33 (0)1 40 62 56 64

Aurélien de Chomereau + 33 (0)1 40 62 58 25